We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$417M
AUM Growth
-$24.5M
Cap. Flow
-$15.1M
Cap. Flow %
-3.63%
Top 10 Hldgs %
23.16%
Holding
1,096
New
51
Increased
294
Reduced
328
Closed
50

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$7.46M
2
LIN icon
Linde
LIN
+$6.13M
3
LOGI icon
Logitech
LOGI
+$3.75M
4
KO icon
Coca-Cola
KO
+$1.49M
5
AMZN icon
Amazon
AMZN
+$990K

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$14.3M
2
IVE icon
iShares S&P 500 Value ETF
IVE
+$7.54M
3
ALC icon
Alcon
ALC
+$5.41M
4
RACE icon
Ferrari
RACE
+$5.16M
5
CNH
CNH Industrial
CNH
+$2.87M

Sector Composition

Rank Sector Weight
1 Financials 15.48%
2 Technology 15.28%
3 Consumer Discretionary 11.12%
4 Healthcare 10.96%
5 Industrials 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WERN icon
401
Werner Enterprises
WERN
$2.42B
$192K 0.05%
+4,328
New +$198K
ENS icon
402
EnerSys
ENS
$6.73B
$191K 0.05%
2,563
-17
-0.7% -$1.51K
VKTX icon
403
Viking Therapeutics
VKTX
$4.09B
$189K 0.05%
30,145
+6,172
+26% +$38.1K
ULTA icon
404
Ulta Beauty
ULTA
$20.6B
$189K 0.05%
524
NGD
405
DELISTED
New Gold Inc
NGD
$189K 0.05%
+178,266
New +$245K
HTBK
406
DELISTED
Heritage Commerce
HTBK
$189K 0.05%
16,226
+2,371
+17% +$26.5K
UFO icon
407
Procure Space ETF
UFO
$607M
$188K 0.05%
6,200
EXPE icon
408
Expedia Group
EXPE
$33.4B
$188K 0.05%
1,146
INVH icon
409
Invitation Homes
INVH
$17.6B
$187K 0.04%
4,881
+849
+21% +$34K
EEMA icon
410
iShares MSCI Emerging Markets Asia ETF
EEMA
$824M
$186K 0.04%
2,204
VRTX icon
411
Vertex Pharmaceuticals
VRTX
$122B
$186K 0.04%
1,024
+70
+7% +$13.7K
GTM
412
ZoomInfo Technologies
GTM
$922M
$185K 0.04%
3,024
+1,669
+123% +$99.8K
URG
413
Ur-Energy
URG
$493M
$180K 0.04%
104,636
+21,167
+25% +$28.4K
KC
414
Kingsoft Cloud Holdings
KC
$2.98B
$180K 0.04%
6,347
-3,825
-38% -$114K
LULU icon
415
lululemon athletica
LULU
$13.3B
$180K 0.04%
444
-74
-14% -$29.6K
BE icon
416
Bloom Energy
BE
$51.6B
$179K 0.04%
9,582
-57
-0.6% -$1.21K
MIRM icon
417
Mirum Pharmaceuticals
MIRM
$6.96B
$179K 0.04%
8,999
+373
+4% +$6.07K
FRPT icon
418
Freshpet
FRPT
$2.95B
$179K 0.04%
1,254
-207
-14% -$29.6K
TGTX icon
419
TG Therapeutics
TGTX
$8.54B
$179K 0.04%
5,368
-3,563
-40% -$110K
VFH icon
420
Vanguard Financials ETF
VFH
$13.4B
$179K 0.04%
+1,928
New +$178K
PSA icon
421
Public Storage
PSA
$60.7B
$179K 0.04%
601
+102
+20% +$32K
WOLF icon
422
Wolfspeed
WOLF
$1.18B
$179K 0.04%
2,211
-429
-16% -$38.1K
CHGG icon
423
Chegg
CHGG
$108M
$178K 0.04%
2,615
-504
-16% -$41K
PM icon
424
CALL
Philip Morris
PM
$305B
$177K 0.04%
87
REGI
425
DELISTED
Renewable Energy Group, Inc.
REGI
$176K 0.04%
3,500
-677
-16% -$37K

Similar funds

Exane Derivatives's Q3 2021 Portfolio in Review

As of Q3 2021, Exane Derivatives held 1,096 positions worth $417M, down 5.6% from $441M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $15.1M in Q3 2021, closing 50 positions and reducing 328 holdings. Its most notable exit was Kraft Heinz, an estimated $1.62M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Exane Derivatives opened a new position in Discovery, Inc. Series C Common Stock worth $796K.

  • Exane Derivatives's largest Q3 2021 buy was Discovery, Inc. Series C Common Stock: 32,809 shares worth $796K.
  • Exane Derivatives added most to UBS Group in Q3 2021, an estimated $7.46M increase.
  • Exane Derivatives's biggest Q3 2021 reduction was Stellantis, cutting an estimated $14.3M.
  • Exane Derivatives fully exited Kraft Heinz in Q3 2021, selling an estimated $1.62M.
  • Exane Derivatives's ten largest holdings make up 23% of its $417M portfolio in Q3 2021.
  • Exane Derivatives opened 51 new positions and closed 50 in Q3 2021.
  • Exane Derivatives's portfolio value fell 5.6% quarter-over-quarter to $417M.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.